An open‐label phase II study: The efficiency and safety of anlotinib + eribulin in patients with HER2 ‐negative metastatic breast cancer

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Xinyu Wu, Fei Qu, Yijia Hua, Rongrong Lu, Nan Jin, Yan Liang, Chunxiao Sun, Fan Yang, Wei Li, Xiang Huang, Yongmei Yin
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	International Journal of Cancer
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet